Valid Ghana · FDA Ghana

BOB MARTIN TICK AND FLEA POWDER (DOGS AND PUPPIES)

PROPOXUR

FDA/V.255-11192 PROPOXUR INN generic

What it does

Propoxur is a pesticide used to control pests and insects in various settings.

Commonly used for: insect control (pest management)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/V.255-11192
Registration date
2025-11-10
Expiry date
2030-12-01
Status
Valid
Active ingredient
PROPOXUR
Dosage form
PROPOXUR
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Medpet
Applicant / LTR
DOUBLE A LTD
Country of origin
SOUTH AFRICA

Source: Food and Drugs Authority · fetched 2026-06-19 04:00:21 · updated 2026-10-16 04:00:13

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About this medicine

Propoxur is a pesticide used to control pests and insects in various settings.

What it treats

  • insect control (pest management)

How it works

Propoxur works by disrupting the nervous system of insects, leading to their death.

Who it's for

This product is for use in agricultural and pest control settings, not for personal use.

Cautions

  • • Avoid inhaling or coming into contact with skin.
  • • Keep away from children and pets.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: propoxur

BNF-referenced

Propoxur is a carbamate insecticide that acts as a cholinesterase inhibitor. It is primarily used in agriculture and pest control due to its ability to disrupt the normal functioning of the nervous system in insects. Propoxur's mechanism involves the irreversible binding to acetylcholinesterase, leading to increased levels of acetylcholine, which results in overstimulation of the nervous system. While its use is effective in controlling pests, concerns regarding its carcinogenic potential and effects in humans exist.

Indications

  • Control of pests in agricultural settings
  • Insecticide for household use
  • Pest management in public health

Dosage

Children: Refer to specific guidelines for application based on context and formulation. Propoxur is not intended for

Adults: Refer to specific guidelines for application based on context and formulation. Propoxur is not intended for direct human consumption or therapeutic use.

Mechanism of action

Propoxur exerts its effects by inhibiting the enzyme acetylcholinesterase, leading to the accumulation of acetylcholine at neuromuscular junctions and synapses. This accumulation results in prolonged stimulation of both muscarinic and nicotinic receptors, which can lead to symptoms of poisoning. The drug's metabolites, which include phenolic compounds, may also contribute to its oncogenic potential at high doses in animal studies, although relevance to human health remains uncertain.

Pharmacodynamics

As a cholinesterase inhibitor, propoxur increases synaptic concentrations of acetylcholine, causing prolonged stimulation of cholinergic receptors. This mechanism mirrors the effects of other anticholinesterase agents and can lead to symptoms such as muscle twitching, respiratory distress, and potentially fatal convulsions in cases of overdose. The effects on the central nervous system are minimal due to limited penetration of the blood-brain barrier.

Pharmacokinetics

Propoxur is rapidly absorbed following exposure, with its effects manifesting shortly thereafter. The drug undergoes metabolic transformation, with spontaneous hydrolysis of the carbamate-cholinesterase complex occurring in vivo, leading to a resolution of symptoms typically within 24 hours. The elimination half-life and specific metabolic pathways are not well-characterized, but due to its mode of action, the duration of effects correlates with the degree of cholinesterase inhibition.

Adverse effects

  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal cramps
  • Muscle twitching
  • Salivation
  • Sweating
  • Lacrimation
  • Miosis
  • Bradycardia
  • Hypotension

Interactions

  • Anticholinergic agents may antagonize the effects of propoxur.
  • Concurrent use with other cholinesterase inhibitors may lead to additive effects.

Precautions

  • Use with caution in patients with asthma or other respiratory conditions due to potential bronchoconstriction.
  • Caution is advised in patients with a history of seizures or epilepsy.
  • Monitor for signs of cholinergic toxicity.

Pregnancy

Propoxur should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, as there is insufficient data on its safety.

Breast-feeding

Due to the potential for serious adverse effects, it is recommended to avoid use during breastfeeding.

Storage

Store in a tightly closed container at room temperature, away from moisture and heat.

Formulations

  • Tablets
  • Suspension

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: propoxur

PubChem CID 4944

Molecular formula: C11H15NO3

Mechanism of action

/A/ review of studies /was undertaken/ to evaluate mechanisms of rat urinary bladder tumors ... Propoxur or a metabolite was postulated to operate on or with growth factors to elicit hyperplasia and eventual tumor development. Since some propoxur metabolites are phenols, and since some phenols share with propoxur the property of being urinary bladder oncogens only at extremely high dose levels, threshold effects may be present. Low urinary pH was noted to inhibit binding of epidermal growth factor, which is abundant in rat urine. This is consistent with rat studies, in which pH reduction markedly reduced the extent of hyperplasia. Perspectives offered in this discussion suggest that propoxur-induced tumors in rats may not be relevant to man, but the "possible adverse effect" designation remains until more definitive evidence can be obtained. Carbamylation of acetylcholinesterase produces accumulation of acetylcholine and the picture of muscarinic and nicotinic poisoning. Spontaneous hydrolysis of the carbamate-cholinesterase complex occurs in vivo, leading to the disappearance of clinical effects within 24 hours. Penetration of the blood-brain barrier by the carbamates is insignificant; for this reason, few CNS symptoms occur. Propoxur inhibits cholinesterase & this effect is apparently the basis of its toxic action.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.